In Vitro診断(IVD)の世界市場予測(~2023年):IVD装置、IVD試薬

MarketsandMarketsが発行した調査報告書(MAM-MD-3609)
◆英語タイトル:In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023
◆商品コード:MAM-MD-3609
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年3月27日
◆ページ数:407
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarketsが発行した当調査レポートでは、In Vitro診断(IVD)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別分析、技術別分析、用途別分析、地域別分析、In Vitro診断(IVD)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・In Vitro診断(IVD)の世界市場:市場インサイト
・In Vitro診断(IVD)の世界市場:市場概観/市場動向
・In Vitro診断(IVD)の世界市場:産業動向
・In Vitro診断(IVD)の世界市場:市場シェア分析
・In Vitro診断(IVD)の世界市場:製品別分析/市場規模
・In Vitro診断(IVD)の世界市場:技術別分析/市場規模
・In Vitro診断(IVD)の世界市場:用途別分析/市場規模
・In Vitro診断(IVD)の世界市場:地域別分析/市場規模
・In Vitro診断(IVD)のアジア市場規模予測
・In Vitro診断(IVD)のヨーロッパ市場規模予測
・In Vitro診断(IVD)のアメリカ市場規模予測
・In Vitro診断(IVD)の世界市場動向
・In Vitro診断(IVD)の世界市場:競争状況
・In Vitro診断(IVD)の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

“The in vitro diagnostics market is projected to grow at a CAGR of 5.2%.”The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion diagnostics, and emerging economies are expected to offer significant growth opportunities for market players during the forecast period. However, the unfavorable reimbursement scenario, changing regulatory landscape, and operational barriers faced in conducting diagnostic tests are all expected to challenge market growth to a certain extent in the coming years.

“The reagents & kits segment is expected to dominate the market during the forecast period.”
In 2018, on the basis of product & service, the reagents & kits segment is expected to account for the largest share of the market.The large share of this segment is primarily attributed to the increased accessibility and demand for reagents and the rising number of IVD tests conducted.
“The oncology segment is projected to be the fastest growing during the forecast period.”
In 2018, on the basis of application, the oncology segment is expected to register the highest growth rate during the forecast period, owing to the increasing prevalence of cancer and the introduction of a number of diagnostic tests such as Oncomine Dx Target Test and Oncomine Solid Tumor kits (Thermo Fisher Scientific) for NSCLC and PTEN/ERG FISH and UroVysion FISH tests for the detection of bladder cancer and treatment assessment of prostate cancer.

“Asia Pacific is expected to register the highest growth rate during the forecast period.”
In this report, the IVD market is divided into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to the huge demand for better healthcare services; increasing incidence of chronic and infectious diseases; rapid development in the healthcare infrastructure of developing countries such as India, China, and South Korea; growing healthcare research investments in this region; and increasing per capita income of the middle-class population in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 – 22%, Tier 2 – 53% and Tier 3 – 25%
• By Designation – C-level – 45%, Director-level – 30%, Others – 25%
• By Region – North America – 55%, Europe – 25%, APAC – 10%, Latin America– 5%, and Middle East & Africa – 5%

List of companies profiled in the report

• Roche Diagnostics (Switzerland)
• Siemens Healthineers (Germany)
• Danaher Corporation (US)
• Abbott Laboratories (US)
• Thermo Fisher Scientific (US)
• Johnson & Johnson (US)
• Becton, Dickinson and Company (US)
• Bio-Rad Laboratories (US)
• Sysmex Corporation (Japan)
• bioMérieux (France)
• DiaSorin (Italy)
• Ortho Clinical Diagnostics (US)
• QIAGEN (Germany)
• Agilent Technologies (US)

Research Coverage
This report studies the in vitro diagnostics market based on product & service, technology, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall in vitro diagnostics market and its segments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 29
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Breakdown of primaries 32
2.1.2.2 Key data from primary sources 33
2.1.2.3 Key industry insights 34
2.2 MARKET SIZE ESTIMATION 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 37
2.4 MARKET SHARE ESTIMATION 38
2.5 ASSUMPTIONS FOR THE STUDY 38
3 EXECUTIVE SUMMARY 39
4 PREMIUM INSIGHTS 46
4.1 IN VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW 46
4.2 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 47
4.3 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 48
4.4 GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET 49
4.5 IN VITRO DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED MARKETS 49

5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 51
5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 51
5.2.1.2 Increasing adoption of fully automated instruments and automation in laboratories 53
5.2.1.3 Growing awareness on personalized medicine 54
5.2.1.4 Increasing adoption of point-of-care testing 54
5.2.2 RESTRAINT 55
5.2.2.1 Unfavorable reimbursement scenario 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Development of condition-specific markers and tests 55
5.2.3.2 Growing significance of companion diagnostics 56
5.2.3.3 Growth opportunities in emerging countries 57
5.2.4 CHALLENGES 58
5.2.4.1 Changing regulatory landscape 58
5.2.4.2 Operational barriers faced in conducting diagnostic tests 59
6 INDUSTRY INSIGHTS 60
6.1 INTRODUCTION 60
6.2 INDUSTRY TRENDS 60
6.2.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES 60
6.2.2 MICROFLUIDICS-BASED POC AND LOC DIAGNOSTIC DEVICES FOR LABORATORY TESTING 61
6.2.3 RISE IN NUMBER OF REAGENT RENTAL AGREEMENTS 61
6.3 REGULATORY OVERVIEW 62
6.3.1 US 62
6.3.2 CANADA 64
6.3.3 EUROPE 65
6.3.4 JAPAN 67
6.3.5 CHINA 68
6.3.6 INDIA 68
6.3.7 INDONESIA 69
6.3.8 RUSSIA 70
6.3.9 SAUDI ARABIA 71
6.3.10 MEXICO 71
6.3.11 BRAZIL 72
6.3.12 SOUTH KOREA 73
6.4 VENDOR BENCHMARKING 74

7 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 76
7.1 INTRODUCTION 77
7.2 REAGENTS & KITS 78
7.3 INSTRUMENTS 80
7.3.1 FULLY AUTOMATED INSTRUMENTS 82
7.3.2 SEMI-AUTOMATED INSTRUMENTS 85
7.3.3 OTHER INSTRUMENTS 86
7.4 DATA MANAGEMENT SOFTWARE 87
7.5 SERVICES 89
8 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 92
8.1 INTRODUCTION 93
8.2 IMMUNOASSAY/IMMUNOCHEMISTRY 94
8.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY 98
8.2.1.1 Chemiluminescence immunoassays 101
8.2.1.2 Fluorescence immunoassays 103
8.2.1.3 Colorimetric immunoassays 105
8.2.2 RADIOIMMUNOASSAY 106
8.2.3 RAPID TEST 108
8.2.4 WESTERN BLOTTING 110
8.2.5 ENZYME-LINKED IMMUNOSPOT ASSAYS 112
8.3 CLINICAL CHEMISTRY 113
8.3.1 BASIC METABOLIC PANEL 118
8.3.2 ELECTROLYTE PANEL 120
8.3.3 LIVER PANEL 121
8.3.4 LIPID PROFILE 122
8.3.5 RENAL PROFILE 123
8.3.6 THYROID FUNCTION PANEL 124
8.3.7 SPECIALTY CHEMICAL TESTS 125
8.4 MOLECULAR DIAGNOSTICS 126
8.4.1 POLYMERASE CHAIN REACTION 129
8.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY 132
8.4.3 MICROARRAY 133
8.4.4 HYBRIDIZATION 135
8.4.5 DNA SEQUENCING & NEXT-GENERATION SEQUENCING 136
8.4.6 OTHER MDX TECHNOLOGIES 138
8.5 MICROBIOLOGY 140
8.6 HEMATOLOGY 142
8.7 COAGULATION AND HEMOSTASIS 145
8.8 URINALYSIS 148
8.9 OTHER IVD TECHNOLOGIES 150
9 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION 153
9.1 INTRODUCTION 154
9.2 INFECTIOUS DISEASES 155
9.3 DIABETES 157
9.4 ONCOLOGY 159
9.5 CARDIOLOGY 161
9.6 AUTOIMMUNE DISEASES 162
9.7 NEPHROLOGY 164
9.8 DRUG TESTING/PHARMACOGENOMICS 166
9.9 HIV/AIDS 168
9.10 OTHER APPLICATIONS 169
10 IN VITRO DIAGNOSTICS MARKET, BY END USER 171
10.1 INTRODUCTION 172
10.2 HOSPITALS 173
10.3 LABORATORIES 175
10.3.1 LARGE/REFERENCE LABORATORIES 177
10.3.2 MEDIUM-SIZED LABORATORIES 178
10.3.3 SMALL LABORATORIES 179
10.4 POINT-OF-CARE TESTING 180
10.5 PATIENT SELF-TESTING 182
10.6 ACADEMIC INSTITUTES 183
10.7 OTHER END USERS 184
11 IN VITRO DIAGNOSTICS MARKET, BY REGION 185
11.1 INTRODUCTION 186
11.2 NORTH AMERICA 188
11.2.1 US 193
11.2.2 CANADA 197
11.3 EUROPE 201
11.3.1 GERMANY 206
11.3.2 FRANCE 210
11.3.3 UK 213
11.3.4 ITALY 217
11.3.5 SPAIN 220
11.3.6 RUSSIA 224
11.3.7 REST OF EUROPE 227

11.4 ASIA PACIFIC 230
11.4.1 JAPAN 235
11.4.2 CHINA 239
11.4.3 INDIA 242
11.4.4 SOUTH KOREA 246
11.4.5 INDONESIA 250
11.4.6 REST OF ASIA PACIFIC 253
11.5 LATIN AMERICA 256
11.5.1 BRAZIL 260
11.5.2 MEXICO 264
11.5.3 REST OF LATIN AMERICA 268
11.6 MIDDLE EAST & AFRICA 271
11.6.1 SAUDI ARABIA 274
11.6.2 REST OF THE MIDDLE EAST & AFRICA 278
12 COMPETITIVE LANDSCAPE 281
12.1 INTRODUCTION 281
12.2 MARKET SHARE ANALYSIS 282
12.2.1 MARKET SHARE ANALYSIS, BY TECHNOLOGY 284
12.2.1.1 Clinical chemistry 284
12.2.1.2 Immunochemistry/Immunoassay 285
12.2.1.3 Microbiology 285
12.2.1.4 Molecular Diagnostics 286
12.2.1.5 Hematology 287
12.2.1.6 Coagulation 288
12.3 COMPETITIVE SITUATION AND TRENDS 289
12.3.1 PRODUCT LAUNCHES 289
12.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 290
12.3.3 ACQUISITIONS 291
12.3.4 EXPANSIONS 292
12.3.5 OTHER STRATEGIES 293
13 COMPANY PROFILES 294
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
13.1 ROCHE DIAGNOSTICS 294
13.2 DANAHER CORPORATION 302
13.3 ABBOTT LABORATORIES, INC. 313
13.4 SIEMENS AG 319
13.5 SYSMEX CORPORATION 326
13.6 THERMO FISHER SCIENTIFIC 332
13.7 BECTON, DICKINSON AND COMPANY 343
13.8 BIOMÉRIEUX SA 349
13.9 BIO-RAD LABORATORIES, INC. 355
13.10 JOHNSON & JOHNSON 363
13.11 AGILENT TECHNOLOGIES 367
13.12 QIAGEN 373
13.13 DIASORIN 380
13.14 ORTHO CLINICAL DIAGNOSTICS (A PART OF CARLYLE GROUP) 390
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
14 APPENDIX 393
14.1 INSIGHTS OF INDUSTRY EXPERTS 393
14.2 DISCUSSION GUIDE 394
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 399
14.4 NTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 401
14.5 AVAILABLE CUSTOMIZATIONS 403
14.6 RELATED REPORTS 404
14.7 AUTHOR DETAILS 405

LIST OF TABLES

TABLE 1 GLOBAL IVD MARKET SNAPSHOT 39
TABLE 2 NUMBER OF PEOPLE WITH DIABETES, BY REGION,
2015 VS. 2040 (MILLION INDIVIDUALS) 52
TABLE 3 FULLY AUTOMATED SYSTEMS LAUNCHED BY KEY PLAYERS 53
TABLE 4 NEW TESTS LAUNCHED BY KEY PLAYERS 56
TABLE 5 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES 62
TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 62
TABLE 7 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 64
TABLE 8 EUROPE: CLASSIFICATION OF IVD DEVICES 65
TABLE 9 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 66
TABLE 10 JAPAN: CLASSIFICATION OF IVD REAGENTS 67
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 68
TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 68
TABLE 13 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 69
TABLE 14 INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES 70
TABLE 15 RUSSIA: CLASSIFICATION OF IVD DEVICES 70
TABLE 16 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 71
TABLE 17 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72
TABLE 18 BRAZIL: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 73
TABLE 19 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 73
TABLE 20 IN VITRO DIAGNOSTIC PRODUCTS & SERVICES MARKET:
PRODUCT PORTFOLIO ANALYSIS 74
TABLE 21 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 77
TABLE 22 IN VITRO DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 79
TABLE 23 IN VITRO DIAGNOSTIC REAGENTS & KITS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 80
TABLE 24 IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 81
TABLE 25 IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 81
TABLE 26 IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 82
TABLE 27 MAJOR LAB AUTOMATION SYSTEMS & FULLY AUTOMATED INSTRUMENTS IN THE MARKET 83
TABLE 28 FULLY AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 84
TABLE 29 SEMI-AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 85
TABLE 30 OTHER IVD INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 86
TABLE 31 KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN THE MARKET 87
TABLE 32 IN VITRO DIAGNOSTIC DATA MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 88
TABLE 33 IN VITRO DIAGNOSTIC DATA MANAGEMENT SOFTWARE MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 89
TABLE 34 IN VITRO DIAGNOSTIC SERVICES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 90
TABLE 35 IN VITRO DIAGNOSTIC SERVICES MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 91
TABLE 36 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 94
TABLE 37 IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN THE MARKET 95
TABLE 38 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY TYPE,
2016–2023 (USD MILLION) 97
TABLE 39 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 97
TABLE 40 ELISA ANALYZERS AVAILABLE IN THE MARKET 99
TABLE 41 ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 100
TABLE 42 ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET, BY TYPE,
2016–2023 (USD MILLION) 101
TABLE 43 CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN THE MARKET 102
TABLE 44 CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 103
TABLE 45 FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 104
TABLE 46 COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 105
TABLE 47 RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 107
TABLE 48 RAPID TESTS AVAILABLE IN THE MARKET 108
TABLE 49 RAPID TEST MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 109
TABLE 50 WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET 110
TABLE 51 WESTERN BLOTTING MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 111
TABLE 52 ELISPOT ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 112
TABLE 53 CLINICAL CHEMISTRY ANALYZERS FOR HIGH- AND MID-VOLUME LABORATORIES 113
TABLE 54 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES 115
TABLE 55 BLOOD GAS ANALYZERS AVAILABLE IN THE MARKET 116
TABLE 56 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 117
TABLE 57 CLINICAL CHEMISTRY MARKET, BY TEST TYPE, 2016–2023 (USD MILLION) 118
TABLE 58 BASIC METABOLIC PANEL MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 119
TABLE 59 ELECTROLYTE PANEL MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 120
TABLE 60 LIVER PANEL MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 121
TABLE 61 LIPID PROFILE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 122
TABLE 62 RENAL PROFILE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 123
TABLE 63 THYROID FUNCTION PANEL MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 124
TABLE 64 SPECIALTY CHEMICAL TESTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 125
TABLE 65 AUTOMATED MOLECULAR PLATFORMS, BY KEY MARKET PLAYER 126
TABLE 66 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 128
TABLE 67 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 129
TABLE 68 PCR INSTRUMENTS, BY KEY MARKET PLAYER 130
TABLE 69 PCR MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 131
TABLE 70 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 132
TABLE 71 MICROARRAY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 134
TABLE 72 HYBRIDIZATION MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 135
TABLE 73 NGS INSTRUMENTS, BY KEY MARKET PLAYER 137
TABLE 74 DNA SEQUENCING & NGS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 137
TABLE 75 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 139
TABLE 76 MICROBIOLOGY INSTRUMENTS, BY KEY MARKET PLAYER 140
TABLE 77 MICROBIOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 141
TABLE 78 HEMATOLOGY ANALYZERS, BY KEY MARKET PLAYER 143
TABLE 79 HEMATOLOGY MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 144
TABLE 80 COAGULATION ANALYZERS, BY KEY MARKET PLAYER 145
TABLE 81 POINT OF CARE/SELF-MONITORING COAGULATION ANALYZERS,
BY KEY MARKET PLAYER 147
TABLE 82 COAGULATION & HEMOSTASIS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 147
TABLE 83 URINALYSIS INSTRUMENTS, BY KEY MARKET PLAYER 148
TABLE 84 URINALYSIS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 149
TABLE 85 BLOOD GLUCOSE TESTING SYSTEMS, BY KEY MARKET PLAYER 150
TABLE 86 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS OFFERED
BY KEY MARKET PLAYERS 151
TABLE 87 OTHER IVD TECHNOLOGIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 152
TABLE 88 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 154
TABLE 89 IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,
2016–2023 (USD MILLION) 156
TABLE 90 GLOBAL DIABETIC PATIENT POPULATION IN 2015 AND 2040 (MILLION) 157
TABLE 91 IN VITRO DIAGNOSTICS MARKET FOR DIABETES, BY COUNTRY,
2016–2023 (USD MILLION) 158
TABLE 92 IN VITRO DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY,
2016–2023 (USD MILLION) 160
TABLE 93 IN VITRO DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY,
2016–2023 (USD MILLION) 161
TABLE 94 IN VITRO DIAGNOSTICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2016–2023 (USD MILLION) 163
TABLE 95 IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGY, BY COUNTRY,
2016–2023 (USD MILLION) 165
TABLE 96 IN VITRO DIAGNOSTICS MARKET FOR DRUG TESTING/PHARMACOGENOMICS,
BY COUNTRY, 2016–2023 (USD MILLION) 167
TABLE 97 IN VITRO DIAGNOSTICS MARKET FOR HIV/AIDS, BY COUNTRY,
2016–2023 (USD MILLION) 169
TABLE 98 IN VITRO DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2016–2023 (USD MILLION) 170
TABLE 99 IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 172
TABLE 100 IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY,
2016–2023 (USD MILLION) 174
TABLE 101 IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 176
TABLE 102 IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY COUNTRY,
2016–2023 (USD MILLION) 176
TABLE 103 LARGE/REFERENCE LABORATORIES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 177
TABLE 104 MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 178
TABLE 105 SMALL LABORATORIES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 179
TABLE 106 IN VITRO DIAGNOSTICS MARKET FOR POC TESTING, BY COUNTRY,
2016–2023 (USD MILLION) 181
TABLE 107 IN VITRO DIAGNOSTICS MARKET FOR PATIENT SELF-TESTING, BY COUNTRY,
2016–2023 (USD MILLION) 182
TABLE 108 IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY,
2016–2023 (USD MILLION) 183
TABLE 109 IN VITRO DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY,
2016–2023 (USD MILLION) 184
TABLE 110 IN VITRO DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 187
TABLE 111 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 189
TABLE 112 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 190
TABLE 113 NORTH AMERICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 190
TABLE 114 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 191
TABLE 115 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 191
TABLE 116 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 192
TABLE 117 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 192
TABLE 118 US: KEY MACROINDICATORS 193
TABLE 119 US: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 194
TABLE 120 US: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 194
TABLE 121 US: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 195
TABLE 122 US: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 195
TABLE 123 US: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 196
TABLE 124 US: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 196
TABLE 125 CANADA: KEY MACROINDICATORS 197
TABLE 126 CANADA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 198
TABLE 127 CANADA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 198
TABLE 128 CANADA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 199
TABLE 129 CANADA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 199
TABLE 130 CANADA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 200
TABLE 131 CANADA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 200
TABLE 132 EUROPE: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 203
TABLE 133 EUROPE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 203
TABLE 134 EUROPE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 204
TABLE 135 EUROPE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 204
TABLE 136 EUROPE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 205
TABLE 137 EUROPE: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 205
TABLE 138 EUROPE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 206
TABLE 139 GERMANY: KEY MACROINDICATORS 206
TABLE 140 GERMANY: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 207
TABLE 141 GERMANY: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 207
TABLE 142 GERMANY: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 208
TABLE 143 GERMANY: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 208
TABLE 144 GERMANY: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 209
TABLE 145 GERMANY: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 209
TABLE 146 FRANCE: KEY MACROINDICATORS 210
TABLE 147 FRANCE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 210
TABLE 148 FRANCE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 211
TABLE 149 FRANCE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 211
TABLE 150 FRANCE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 212
TABLE 151 FRANCE: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 212
TABLE 152 FRANCE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 213
TABLE 153 UK: KEY MACROINDICATORS 214
TABLE 154 UK: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 214
TABLE 155 UK: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 214
TABLE 156 UK: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 215
TABLE 157 UK: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 215
TABLE 158 UK: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 216
TABLE 159 UK: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 216
TABLE 160 ITALY: KEY MACROINDICATORS 217
TABLE 161 ITALY: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 217
TABLE 162 ITALY: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 218
TABLE 163 ITALY: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 218
TABLE 164 ITALY: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 219
TABLE 165 ITALY: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 219
TABLE 166 ITALY: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 220
TABLE 167 SPAIN: KEY MACROINDICATORS 220
TABLE 168 SPAIN: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 221
TABLE 169 SPAIN: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 221
TABLE 170 SPAIN: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 222
TABLE 171 SPAIN: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 222
TABLE 172 SPAIN: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 223
TABLE 173 SPAIN: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 223
TABLE 174 RUSSIA: KEY MACROINDICATORS 224
TABLE 175 RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 224
TABLE 176 RUSSIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 225
TABLE 177 RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 225
TABLE 178 RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 226
TABLE 179 RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 226
TABLE 180 RUSSIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 227
TABLE 181 ROE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 228
TABLE 182 ROE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 228
TABLE 183 ROE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 228
TABLE 184 ROE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 229
TABLE 185 ROE: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 229
TABLE 186 ROE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 230
TABLE 187 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 232
TABLE 188 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 232
TABLE 189 ASIA PACIFIC: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 233
TABLE 190 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 233
TABLE 191 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 234
TABLE 192 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 234
TABLE 193 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 235
TABLE 194 JAPAN: KEY MACROINDICATORS 235
TABLE 195 JAPAN: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 236
TABLE 196 JAPAN: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 236
TABLE 197 JAPAN: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 237
TABLE 198 JAPAN: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 237
TABLE 199 JAPAN: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 238
TABLE 200 JAPAN: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 238
TABLE 201 CHINA: KEY MACROINDICATORS 239
TABLE 202 CHINA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 239
TABLE 203 CHINA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 240
TABLE 204 CHINA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 240
TABLE 205 CHINA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 241
TABLE 206 CHINA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 241
TABLE 207 CHINA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 242
TABLE 208 INDIA: KEY MACROINDICATORS 243
TABLE 209 INDIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 243
TABLE 210 INDIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 244
TABLE 211 INDIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 244
TABLE 212 INDIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 245
TABLE 213 INDIA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 245
TABLE 214 INDIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 246
TABLE 215 SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 247
TABLE 216 SOUTH KOREA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 247
TABLE 217 SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 248
TABLE 218 SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 248
TABLE 219 SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 249
TABLE 220 SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 249
TABLE 221 INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 250
TABLE 222 INDONESIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 251
TABLE 223 INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 251
TABLE 224 INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 252
TABLE 225 INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 252
TABLE 226 INDONESIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 253
TABLE 227 ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 253
TABLE 228 ROAPAC: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 254
TABLE 229 ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 254
TABLE 230 ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 255
TABLE 231 ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 255
TABLE 232 ROAPAC: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 256
TABLE 233 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 257
TABLE 234 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 257
TABLE 235 LATIN AMERICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 257
TABLE 236 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 258
TABLE 237 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 258
TABLE 238 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 259
TABLE 239 LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 259
TABLE 240 BRAZIL: KEY MACROINDICATORS 260
TABLE 241 BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 261
TABLE 242 BRAZIL: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 261
TABLE 243 BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 262
TABLE 244 BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 262
TABLE 245 BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 263
TABLE 246 BRAZIL: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 263
TABLE 247 MEXICO: KEY MACROINDICATORS 264
TABLE 248 MEXICO: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 265
TABLE 249 MEXICO: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 265
TABLE 250 MEXICO: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 266
TABLE 251 MEXICO: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 266
TABLE 252 MEXICO: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 267
TABLE 253 MEXICO: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 267
TABLE 254 ROLA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 268
TABLE 255 ROLA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 268
TABLE 256 ROLA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 269
TABLE 257 ROLA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 269
TABLE 258 ROLA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 270
TABLE 259 ROLA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE,
2016–2023 (USD MILLION) 270
TABLE 260 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 271
TABLE 261 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 271
TABLE 262 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 272
TABLE 263 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 272
TABLE 264 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 273
TABLE 265 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 273
TABLE 266 MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 274
TABLE 267 SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 275
TABLE 268 SAUDI ARABIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 275
TABLE 269 SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 276
TABLE 270 SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 276
TABLE 271 SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 277
TABLE 272 SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 277
TABLE 273 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 278
TABLE 274 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 278
TABLE 275 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2016–2023 (USD MILLION) 279
TABLE 276 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 279
TABLE 277 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET,
BY END USER, 2016–2023 (USD MILLION) 280
TABLE 278 REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016–2023 (USD MILLION) 280
TABLE 279 PRODUCT LAUNCHES, 2014–2018 289
TABLE 280 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014–2017 290
TABLE 281 ACQUISITIONS, 2014–2017 291
TABLE 282 EXPANSIONS, 2015–2017 292
TABLE 283 OTHER STRATEGIES, 2014–2017 293


LIST OF FIGURES

FIGURE 1 MARKET SEGMENTATION 27
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 BOTTOM-UP APPROACH 35
FIGURE 4 TOP-DOWN APPROACH 36
FIGURE 5 DATA TRIANGULATION METHODOLOGY 37
FIGURE 6 IVD MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD BILLION) 40
FIGURE 7 IVD MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION) 41
FIGURE 8 IVD MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD BILLION) 42
FIGURE 9 IMMUNOCHEMISTRY/ IMMUNOASSAY MARKET, BY TYPE,
2018 VS. 2023 (USD BILLION) 42
FIGURE 10 CLINICAL CHEMISTRY MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION) 43
FIGURE 11 MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION) 43
FIGURE 12 IVD MARKET, BY END USER, 2018 VS. 2023 (USD BILLION) 44
FIGURE 13 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET 45
FIGURE 14 RISING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING THE GROWTH OF THE IN VITRO DIAGNOSTICS MARKET 46
FIGURE 15 REAGENTS & KITS COMMANDED THE LARGEST SHARE IN 2017 47
FIGURE 16 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2017 48
FIGURE 17 APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 49
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD 49
FIGURE 19 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
& CHALLENGES 50
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011–2030) 51
FIGURE 21 INCREASE IN GROSS EXPENDITURE ON R&D IN EMERGING COUNTRIES,
2012–2014 58
FIGURE 22 US: REGULATORY PROCESS FOR IVD DEVICES 63
FIGURE 23 CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA 64
FIGURE 24 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 66
FIGURE 25 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN 67
FIGURE 26 INDIA: REGULATORY PROCESS FOR IVD DEVICES 69
FIGURE 27 MEXICO: REGULATORY PROCESS FOR IVD DEVICES 71
FIGURE 28 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES 72
FIGURE 29 REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 77
FIGURE 30 MOLECULAR DIAGNOSTICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2018–2023) 93
FIGURE 31 RAPID TESTS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023) 96
FIGURE 32 ONCOLOGY, THE FASTEST-GROWING APPLICATION SEGMENT OF THE IN VITRO DIAGNOSTICS MARKET 154
FIGURE 33 NUMBER OF PEOPLE LIVING WITH HIV GLOBALLY, 2010–2015 168
FIGURE 34 IN VITRO DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 172
FIGURE 35 NUMBER OF HOSPITALS, BY COUNTRY/REGION (2015) 173
FIGURE 36 NUMBER OF LABORATORIES, BY COUNTRY/REGION (2015) 175
FIGURE 37 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000 VS. 2014 186
FIGURE 38 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2023 187
FIGURE 39 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL IN VITRO DIAGNOSTICS MARKET 188
FIGURE 40 NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET SNAPSHOT 189
FIGURE 41 EUROPE: IN VITRO DIAGNOSTICS MARKET SNAPSHOT 202
FIGURE 42 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET SNAPSHOT 231
FIGURE 43 KEY DEVELOPMENTS IN THE IN VITRO DIAGNOSTIC MARKET FROM 2014 TO 2018 281
FIGURE 44 GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 282
FIGURE 45 GLOBAL CLINICAL CHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017) 284
FIGURE 46 GLOBAL IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017) 285
FIGURE 47 GLOBAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017) 285
FIGURE 48 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYERS (2017) 286
FIGURE 49 GLOBAL HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017) 287
FIGURE 50 GLOBAL CLINICAL COAGULATION ANALYZERS MARKET SHARE ANALYSIS,
BY KEY PLAYERS (2017) 288
FIGURE 51 F. HOFFMANN-LA ROCHE.: COMPANY SNAPSHOT (2016) 294
FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2016) 302
FIGURE 53 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016) 313
FIGURE 54 SIEMENS AG: COMPANY SNAPSHOT (2017) 319
FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2017) 326
FIGURE 56 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016) 332
FIGURE 57 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017) 343
FIGURE 58 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2016) 349
FIGURE 59 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016) 355
FIGURE 60 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2016) 363
FIGURE 61 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2016) 367
FIGURE 62 QIAGEN: COMPANY SNAPSHOT (2016) 373
FIGURE 63 DIASORIN: COMPANY SNAPSHOT (2016) 380


【レポートのキーワード】

In Vitro診断(IVD)、IVD装置、IVD試薬、免疫測定、臨床化学、分子診断法、血液学、尿検査

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ In Vitro診断(IVD)の世界市場予測(~2023年):IVD装置、IVD試薬(In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆